Your browser doesn't support javascript.
loading
Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?
Calliari, Luis Eduardo P; Krakauer, Marcio; Vianna, Andre Gustavo Daher; Ram, Yashesvini; Barbieri, Douglas Eugenio; Xu, Yongjin; Dunn, Timothy C.
Afiliação
  • Calliari LEP; 1Santa Casa de Sao Paulo School of Medical Sciences, São Paulo, Brazil.
  • Krakauer M; Centro de Pesquisa Clínica do Grupo Leforte, São Paulo, Brazil.
  • Vianna AGD; Centro de Diabetes Curitiba, Curitiba, Brazil.
  • Ram Y; Abbott Diabetes Care, Alameda, CA USA.
  • Barbieri DE; Abbott Diabetes Care, Alameda, CA USA.
  • Xu Y; Abbott Diabetes Care, Alameda, CA USA.
  • Dunn TC; Abbott Diabetes Care, Alameda, CA USA.
Diabetol Metab Syndr ; 12: 3, 2020.
Article em En | MEDLINE | ID: mdl-31921360
BACKGROUND: New technologies are changing diabetes treatment and contributing better outcomes in developed countries. To our knowledge, no previous studies have investigated the comparative effect of sensor-based monitoring on glycemic markers in developing countries like Brazil. The present study aims to evaluate the use of intermittent Continuous Glucose Measurements (iCGM) in a developing country, Brazil, regarding (i) frequency of glucose scans, (ii) its association with glycemic markers and (iii) comparison with these findings to those observed in global population data. METHODS: Glucose results were de-identified and uploaded to a dedicated database when Freestyle Libre™ readers were connected to an internet-ready computer. Data between September 2014 and Dec 2018, comprising 688,640 readers and 7,329,052 sensors worldwide, were analysed (including 17,691 readers and 147,166 sensors from Brazil). Scan rate per reader was determined and each reader was sorted into 20 equally-sized rank ordered groups, categorised by scan frequency. Glucose parameters were calculated for each group, including estimated A1c, time above, below and within range identified as 70-180 mg/dL. RESULTS: In Brazil, reader users performed an average of 14 scans per day, while around the world, reader users performed an average of 12 scans per day (p < 0.01). In Brazil dataset, those in the lowest and in the highest groups scanned on average 3.6 and 43.1 times per day had an estimated A1c of 7.56% (59 mmol/mol) and 6.71% (50 mmol/mol), respectively (p < 0.01). Worldwide, the lowest group and the highest groups scanned 3.4 times/day and 37.8 times/day and had an eA1c of 8.14% (65 mmol/mol) and 6.70% (50 mmol/mol), respectively (p < 0.01). For the scan groups in both populations, the time spent above 180 mg/dL decreased as the scan frequency increased. In both Brazil and around the world, as scan frequency increased, time in range (TIR) increased. In Brazil, TIR increased from 14.15 to 16.62 h/day (p < 0.01). Worldwide, TIR increased from 12.06 to 16.97 h/day (p < 0.01). CONCLUSIONS: We conclude that Brazilian users have a high frequency of scans, more frequent than global data. Similarly to the world findings, increased scan frequency is associated with better glycemic control.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies País/Região como assunto: America do sul / Brasil Idioma: En Revista: Diabetol Metab Syndr Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies País/Região como assunto: America do sul / Brasil Idioma: En Revista: Diabetol Metab Syndr Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido